Adagrasib alone, with cetuximab shows ‘encouraging’ activity in advanced colorectal cancer
Adagrasib alone and in combination with cetuximab exhibited promising efficacy compared with historical outcomes among heavily pretreated patients with advanced colorectal cancer who had KRASG12C…